Hyperlipidemia Attenuates the Infarct Size-Limiting Effect of Ischemic Preconditioning: Role of Matrix Metalloproteinase-2 Inhibition

Hyperlipidemia attenuates the cardioprotective effect of preconditioning via unknown mechanisms. We have reported previously that in normolipidemic rats, preconditioning decreased ischemia-induced activation and release of myocardial matrix metalloproteinase (MMP)-2 into the coronary perfusate. Here, we investigated whether hyperlipidemia interferes with the cardioprotective effect of preconditioning through modulation of MMP-2. Hearts isolated from male Wistar rats fed 2% cholesterol-enriched or control chow for 9 weeks were subjected to a preconditioning protocol (three intermittent periods of ischemia/reperfusion of 5-min duration each) or a time-matched nonpreconditioning protocol. This was followed by a test ischemia/reperfusion (30-min ischemia and 120-min reperfusion) in both groups. Preconditioning decreased infarct size in the control but not the cholesterol-fed group. Cardioprotection in the preconditioned control group but not in the cholesterol-fed group was associated with an 18 ± 3% (p < 0.05) inhibition of test ischemia/reperfusion-induced activation and release of myocardial MMP-2 into the perfusate. Myocardial protein levels of tissue inhibitors of MMPs [tissue inhibitor of metalloproteinases (TIMP)-2 and TIMP-4] were not changed in either group. A reduction of infarct size in nonpreconditioned hearts from both control and cholesterol-fed group was produced by the MMP inhibitor ilomastat at 0.25 μM, a concentration producing MMP-2 inhibition comparable with that of preconditioning in the control group. We conclude that hyperlipidemia blocks preconditioning-induced cardioprotection, hyperlipidemia abolishes preconditioning-induced inhibition of myocardial MMP-2 activation and release, preconditioning-induced inhibition of MMP-2 activation and release is not mediated by TIMPs, and pharmacological inhibition of MMPs produces cardioprotection in both normal and hyperlipidemic rats.

[1]  P. Ferdinandy,et al.  Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. , 2005, Chest.

[2]  Gregory E. J. Harding,et al.  Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  Zhonglin Xie,et al.  Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1β* , 2004, Journal of Biological Chemistry.

[4]  Á. Tósaki,et al.  Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma? , 2004, Antioxidants & redox signaling.

[5]  Z. Giricz,et al.  Cholesterol diet‐induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study , 2004, FEBS letters.

[6]  Carlos Fernandez-Patron,et al.  Agonist-Induced Activation of Matrix Metalloproteinase-7 Promotes Vasoconstriction Through the Epidermal Growth Factor–Receptor Pathway , 2004, Circulation research.

[7]  J. Downey,et al.  Preconditioning the myocardium: from cellular physiology to clinical cardiology. , 2003, Physiological reviews.

[8]  Z. Giricz,et al.  Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. , 2003, Cardiovascular research.

[9]  Z. Giricz,et al.  Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis , 2003, Basic Research in Cardiology.

[10]  J. Paramo,et al.  Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. , 2003, Atherosclerosis.

[11]  P. Ferdinandy,et al.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia‐reperfusion injury and preconditioning , 2003, British journal of pharmacology.

[12]  P. Ferdinandy.  Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia , 2003, British journal of pharmacology.

[13]  Péter Ferdinandy,et al.  Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. , 2002, Biochemical and biophysical research communications.

[14]  Y. Miyamoto,et al.  Activation of Matrix Metalloproteinases by Peroxynitrite-induced Protein S-Glutathiolation via Disulfide S-Oxide Formation* , 2001, The Journal of Biological Chemistry.

[15]  P. Ferdinandy,et al.  Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. , 2001, Biochemical and biophysical research communications.

[16]  P. Ferdinandy,et al.  Delayed preconditioning of myocardium: current perspectives , 2001, Basic Research in Cardiology.

[17]  S. Tokuno,et al.  Preconditioning protects the severely atherosclerotic mouse heart. , 2001, The Annals of thoracic surgery.

[18]  D. Kremastinos,et al.  Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits. , 2000, Atherosclerosis.

[19]  M. Radomski,et al.  Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. , 2000, Circulation.

[20]  W. Linz,et al.  ISCHEMIC PRECONDITIONING AND INFARCT MASS: THE EFFECT OF HYPERCHOLESTEROLEMIA AND ENDOTHELIAL DYSFUNCTION , 2000, Clinical and experimental hypertension.

[21]  M. Hori,et al.  Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. , 1999, Journal of the American College of Cardiology.

[22]  Z. Szilvássy,et al.  Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: Role of polyprenyl derivatives and nitric oxide , 1998, Molecular and Cellular Biochemistry.

[23]  Z. Szilvássy,et al.  Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? , 1998, Trends in pharmacological sciences.

[24]  Z. Szilvássy,et al.  Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. , 1997, Journal of molecular and cellular cardiology.

[25]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[26]  Z. Szilvássy,et al.  The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. , 1995, Journal of molecular and cellular cardiology.

[27]  J. Horton,et al.  Regulation of Hepatic 7α-Hydroxylase Expression and Response to Dietary Cholesterol in the Rat and Hamster (*) , 1995, The Journal of Biological Chemistry.

[28]  P. Roach,et al.  The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. , 1993, Biochimica et biophysica acta.

[29]  R. Berge,et al.  Cholesterol induced lipid accumulation in myocardial cells of rats. , 1993, Cardiovascular research.

[30]  J. Brachmann,et al.  Effects of hypercholesterolaemia without ischemia on some electrophysiological and ultrastructural properties of the rabbit heart. , 1981, Journal of molecular and cellular cardiology.

[31]  M. Lalu,et al.  Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. , 2005, European heart journal.

[32]  R. Schulz,et al.  Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. , 2002, Cardiovascular research.